evaluation of efficacy and safety of microneedle skin patch carrying triamcinolone in the treatment of alopecia areata compared to local injection of triamcinolone with a needle

A single-blind clinical trial pilot study of the efficacy and safety of microneedle skin patch carrying triamcinolone in the treatment of alopecia areata compared to local injection of triamcinolone with a needle

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250228064873N3

Enrollment

Registered

2025-10-04

Start date

2025-10-23

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alopecia Areata. Alopecia areata

Interventions

Intervention 1: Control group: Alopecia patches are mapped on a transparent sheet and a graph paper to calculate the area of ??each patch in square centimeters. In the control patch, intralesional inj

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Alopecia areata patient over 18 years of age with independent clinical diagnosis by a dermatologist At least two patches that do not require systemic treatment Alopecia areata limited to the scalp SALT SCORe less than 20% limited to the scalp

Exclusion criteria

Exclusion criteria: Patients who have previously been treated for alopecia areata within the past 12 weeks Have any autoimmune or systemic disease

Design outcomes

Primary

Measure	Time frame
Severity of ALopecia Tool (SALT) Score. Timepoint: Individuals are followed up monthly for up to three months. Before the intervention begins, 1-2-3 months after the intervention. Method of measurement: As observed by a dermatologist and scored according to the relevant system/Scoring is based on clinical and dermoscopy photographs.;Pain. Timepoint: After each treatment session. Method of measurement: Visual Analogue Scale(VAS).	—

Measure

Time frame

Severity of ALopecia Tool (SALT) Score. Timepoint: Individuals are followed up monthly for up to three months. Before the intervention begins, 1-2-3 months after the intervention. Method of measurement: As observed by a dermatologist and scored according to the relevant system/Scoring is based on clinical and dermoscopy photographs.;Pain. Timepoint: After each treatment session. Method of measurement: Visual Analogue Scale(VAS).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactIfa Etesami

Tehran University of Medical Sciences

Ifa.etesami@gmail.com+98 21 5561 8989

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026